Team | Extended Management

Dr. Paul Hebeisen

Head Medicinal Chemistry

Dr. Paul Hebeisen is a highly experienced medicinal chemist with an impressive track record in drug discovery over 28 years of service at F. Hoffmann-La Roche AG, Switzerland. Paul served in various positions, most notably as a Group Leader in Chemistry in the discovery of novel anti-infectives.

Dr. Aurélie Jenn

Head of Regulatory Affairs & Quality Assurance

Dr. Aurélie Jenn, Head of Regulatory Affairs and Quality Assurance, is a pharmacist (Pharm. D) bringing over 20 years of experience in the pharmaceutical industry. In a first part of her career, she worked in Regulatory Affairs / CMC writing for generic products and New Chemical Entities in Switzerland and France, having close interactions and providing support to technical departments.

David Allman

Head of Clinical Operations

David Allman is a biochemist by training and has over 25 years of global experience in the pharmaceutical industry having worked for pharmaceutical companies and leading clinical research organizations as well as applying his expertise in the virtual development arena.

Dr. Emilie Frugier

Head of Intellectual Property

Dr. Frugier is an experienced patent manager and a qualified European Patent Attorney with a focus on supporting small to mid-sized biotech entities in protecting and securing access to intellectual property assets critical to their competitiveness and fundraising.

Dr. Bernhard Hostettler

Intellectual Property Officer

Dr. Bernhard Hostettler, Head of Intellectual Property, originally is an organic chemist. After his Ph.D. at ETH Zürich, Bernhard was active in research for more than 20 years with companies Roche, CIBA, Syngenta and Givaudan.

Michel Petignat

Head of Human Resources

Michel Petignat, Head of Human Resources, is a qualified HR Specialist in the Life Sciences industry. During his long and outstanding professional career, Michel worked as an HR Manager in leading pharma and biotech companies such as Sandoz, Novartis Pharma, Syngenta Crop Protection and Actelion Pharmaceuticals.

Dr. Robert Ettlin

Head of Preclinical Safety

Dr. Robert Ettlin is the Head of Preclinical Safety in Swiss Rockets. After some years in toxicological pathology at F. Hoffmann La Roche Ltd., Ettlin joined Sandoz Ltd. in Basel, where he advanced to Head of Toxicology and later Head of Development Operations Switzerland.

Jörg Honegger

General Counsel

Jörg Honegger, a highly experienced attorney with over 30 years of practical legal experience in consulting and litigation, has been serving as interim General Counsel of Swiss Rockets Incubator and its subsidiary companies.

Dr. Dirk Mossmann

Scientific Project Manager

Dr. Dirk Mossmann is a cancer biologist with broad expertise in mTOR signaling and cancer metabolism. He studied molecular medicine in Freiburg (Germany) and obtained his Ph.D. in the department of biochemistry.

Albert Muntane Casanova

Senior Financial Advisor

Albert Muntane Casanova is an accomplished manager responsible for overseeing the financial activities of the company.